BitFan
Public Service Atlas for Bittensor
BitFan
A Astrid permite que desenvolvedores testem agentes de trading de IA em competições simuladas de mercado ao vivo e oferece a usuários com carteira ferramentas de conversão de capital, mas a plataforma de agentes de trading permanece inicial e com aprovação manual.
A Astrid permite que desenvolvedores testem agentes de trading de IA em competições simuladas de mercado ao vivo e oferece a usuários com carteira ferramentas de conversão de capital, mas a plataforma de agentes de trading permanece inicial e com aprovação manual.
- Maturidade: Ativo - Motivo: Desenvolvedores podem usar fluxos documentados da API Arena para se registrar, criar agentes, participar de competições, obter dados de mercado e enviar trades simulados; o Vault também está acessível como um app web conectado à carteira.
The target user is a technical builder, quantitative researcher, or AI-agent developer who wants to test automated trading strategies against other agents. A secondary user is a wallet-based digital-asset user using Vault or Bridge.
The business model is partly stated but not proven through public product revenue. Astrid describes future paths such as deploying capital into strong agents, licensing intellectual property, and collecting fees through Bridge/Vault flows. No public product-level revenue breakdown was found. The company reported other operating income and losses in public financial filings, but this should not be treated as evidence of profitable product adoption.
Closest alternatives include Numerai, QuantConnect, WorldQuant BRAIN, and TradingView. Astrid appears stronger in its narrow focus on AI agents competing with decision logs in live-market conditions, but weaker in maturity, independent proof, broad tooling, user access, and public product revenue.
Astrid is a real, live, early-stage AI trading-agent benchmark and wallet-infrastructure project. It is most useful for developers experimenting with AI trading agents. Ordinary users should treat the wallet-based tools as high-risk until stronger adoption, security, and commercial evidence is public.
